Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro

PURPOSE: Osteoarthritis (OA) is a prevalent, progressively degenerative disease. Researchers have rigorously documented clinical improvement in participants receiving prolotherapy for OA. The mechanism of action is unknown; therefore, basic science studies are required. One hypothesized mechanism is...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnston, Elisha, Emani, Chandrakanth, Kochan, Andrew, Ghebrehawariat, Kidane, Tyburski, John, Johnston, Michael, Rabago, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719583/
https://www.ncbi.nlm.nih.gov/pubmed/33280075
http://dx.doi.org/10.1186/s40634-020-00312-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719583/
https://www.ncbi.nlm.nih.gov/pubmed/33280075
http://dx.doi.org/10.1186/s40634-020-00312-z

Ejemplares similares